AIM is trading at $0.29 (-6.57%) as financing dilution and listing compliance risks continue to weigh on the stock.

  • Recent pressure is tied to the company’s $2.65 million at-the-market financing and lingering concerns regarding NYSE American compliance.
  • With no new major announcements reported today, the move appears to be continuation selling in a thin, volatile microcap name.
  • AIM is currently decoupling from the broader markets, which are trading higher.